Ker Yu
Last author of the 2010 Journal of Biological Chemistry study on mTOR, Maf1 and RNA polymerase III transcription.
Wyeth Research, Pearl River, NY
Ker Yu is last and corresponding author of SHO2010, the study that used a Wyeth mTOR active-site inhibitor to show that mTOR controls Maf1 phosphorylation and thereby the output of RNA polymerase III in cancer cells. In PubMed Ker Yu is listed in Discovery Oncology at Wyeth Research in Pearl River, New York.
Milestones in the Atlas
A selection, not a full bibliography: only papers that meet the Atlas inclusion criteria.
| Year | Evidence | Study |
|---|---|---|
| 2010 | M | Requirement of the mTOR kinase for the regulation of Maf1 phosphorylation and control of RNA polymerase III-dependent transcription in cancer cells SHO2010 Last author. mTOR kinase activity is needed to keep Maf1 phosphorylated and Pol III transcription on. |
Co-authors in the Atlas 1
People with a profile here who share at least one study with Ker Yu.
ShowHide
- Boris Shor First author of the 2010 Journal of Biological Chemistry study on mTOR, Maf1 and RNA polymerase III transcription.
Every researcher with a profile →
Thank you. That helps us know which pages have been read by someone who knows the work.
Thank you. We will check it and correct the page.
Thank you. Your answer was counted anonymously.